Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,717.26 -2,078.67 (-3.31%) CMC Crypto 200
1,261.05 -96.96 (-7.14%)
Kymera Therapeutics, Inc. (KYMR)
After hours:
| Previous close | 38.61 |
| Open | 38.69 |
| Bid | 37.76 x 100 |
| Ask | 37.93 x 100 |
| Day's range | 37.66 - 38.93 |
| 52-week range | 9.60 - 45.31 |
| Volume | |
| Avg. volume | 610,572 |
| Market cap | 2.369B |
| Beta (5Y monthly) | 2.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.46 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 51.21 |
GlobeNewswireKymera Therapeutics to Participate in Upcoming May Investor Conferences
WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events: BofA Securities 2024 Health Care Conference in Las Vegas, NV on May 15 at 4:20 p.m. PT; andTD Cowen 5th Annual Oncology Innovation Virtual Summit on May 28 at 1:
Simply Wall St.Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
It's been a pretty great week for Kymera Therapeutics, Inc. ( NASDAQ:KYMR ) shareholders, with its shares surging 12...
Insider MonkeyKymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript May 3, 2024 Kymera Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Kymera Therapeutics First Quarter 2024 Results Conference Call. All participants will […]
